Vaccine protection infection cynomolgus monkeys aim study protection infectious human immunodeficiency virus type challenge cynomolgus macaques active immunization whole virus vaccine monkeys intramuscular im injections viral preparation micrograms incomplete Freund adjuvant IFA im injections micrograms viral protein iscoms cynomolgus monkeys unvaccinated controls weeks last booster animal infectious doses live monkeys antibodies envelope core proteins challenge exposure animals virus IFA detectable neutralizing antibodies monkeys virus IFA evidence infection months challenge live virus blood lymph node cells animals naive cynomolgus monkeys recipients free infection contrast virus nonimmunized animals animals iscom-associated viral antigens low content envelope antigen demonstration vaccine-induced protection nonhuman primate raises effective immunization HIV infections humans 